Navigation Links
CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine
Date:8/4/2009

banning a drug).

It is searchable by drug name and age group and includes who reported the psychiatric drug reaction (doctor, pharmacist, consumer, etc.). It also includes the top 20 reported adverse reactions to all psychiatric drugs to the FDA and combined summaries of all psychiatric drug reactions for the years 2004-2006 and 2004-2008.

Since the reform of the Prescription Drug User Fee Act (PDUFA) in 2007, ads for psychiatric and other drugs must include statements encouraging consumers to report adverse drug reactions to the FDA's MedWatch system--Adverse Events Reporting System (AERS). However, consumers or doctors attempting to access the AERS online were confounded by a system so complex that it was impossible to use. Although the FDA should have made the information collected readily accessible, it failed in that duty to the public. It took a computer programmer over 1,000 hours to decipher four years' worth of data to make this information available.

The programmer identified the main psychiatric drugs in the AERS, wading through quarterly reports of seven different reporting systems, including the drug name, demographics, adverse reactions, patient outcomes, reporting source, therapy start and end dates and the indication (diagnosis). The result: A database and search engine that unravels the 94,000 pages of codified psychiatric drug adverse reactions reported each year from 2004-2006 and 2004-2008 to the FDA's MedWatch system.

Reporting of adverse reactions to psychiatric drugs by doctors, pharmacists, other health care providers and consumers once those drugs are out in the consumer market, is fundamental to drug safety monitoring. Yet these reports have been frequently ignored or dismissed
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Samarion Announces Partnership With Adesta to Install the SamarionSolution Nationwide
2. EPIX Pharmaceuticals, Inc. Announces August 25, 2009 for the Auction Sale of Equipment and September 30, 2009 for the Auction Sale of the Intellectual Property
3. Ferring Pharmaceuticals Announces Trade Name FIRMAGON(R) (degarelix for injection) for Advanced Prostate Cancer Treatment
4. Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 First Quarter Financial Results
5. Presidents Council Announces Top 5 Winners of 2009 National Presidents Challenge
6. Arcadia Resources Announces Webcast of Its Fiscal 2010 First Quarter Conference Call
7. West Announces Second Quarter 2009 Results
8. Rigel Announces Second Quarter 2009 Financial Results
9. CorVel Announces Revenues and Earnings
10. Cardiome Announces Management Transition
11. Hologic Announces Third Quarter Fiscal 2009 Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine
CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine
(Date:12/14/2009)... government controlled health care, before moving to the U.S. to practice ... his new book, Health Reform: The End of the American Revolution?, ... its threat to real health care! , ... (PRWEB) ... from Minnesota, warns Americans not to sell out their liberty for ...
(Date:12/14/2009)... up 900-Member Physician Staff , ... La Jolla, Calif. ... elected Marc Sedwitz, MD, as the new chief of staff of ... the 900-member physician team on Jan. 1, 2010. , , , ... staff liaison to Scripps La Jolla’s administrative staff and its board ...
(Date:12/14/2009)... procedures vary widely and are higher than generally thought, raising concerns ... by University of California, San Francisco (UCSF) imaging specialists. ... ... -- Radiation doses from common CT procedures vary widely and are ... according to a new study led by University of California, ...
(Date:12/14/2009)... facilities (SNFs) in Ohio are making major changes in ... 92 percent increase in the state-imposed Medicaid bed tax ... per day, scheduled for December 15. The increase ... $17,520 to the state each month, or $210,240 per ... Nearly 96 percent of skilled nursing facilities responding to ...
(Date:12/14/2009)... Pasierb, President ,, NEW YORK, Dec. 14 ... the Future study (MTF) -- the largest survey on ... 12th graders -- underscores that teens, intentional abuse of ... a cause for concern, with an alarming number of ... relatives. ,, Teen Abuse of Medication ...
Breaking Medicine News(10 mins):Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 2Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 3Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 4Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 5Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 2Health News:Survey Shows Tax Increase Forcing Ohio Skilled Nursing Facilities to Make Cuts 3Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3
... In a ceremony,attended by Ohio,s physician leaders, ... of the most sweeping physician-insurance industry,contract reform bills ... law, which will take effect in ninety days, ... the contracting process,fairness in contracting, and a standardized ...
... 75 group-randomized cancer trials over a five-year stretch shows ... statistical methods to analyze the results. The review suggests ... prevent disease or reduce cancer risks were effective when ... than a third of the trials contained statistical analyses ...
... /Xinhua-PRNewswire/ -- China Medicine,Corporation (OTC Bulletin Board: ... developer and distributor of prescription and over ... and,dietary supplements, medical devices, and medical formulations ... call at 9:00 a.m. Eastern Time,on Thursday, ...
... Blunt (Mo.) issued the following statement today after the ... that,Social Security and Medicare will deplete their respective trust ... a solemn reminder that we do not have time ... deal with the fiscal,emergency Social Security and Medicare are ...
... Survival, reproduction rates are decreased in those born early, ... The effects of premature birth last long after a ... study finds. , The risk of mortality is increased ... and try to start families of their own, their ...
... Calegari has been,appointed as the Richard Merkin Distinguished ... Dr. Richard Merkin, President of,Heritage Provider Network and ... recipient of his endowment because of his passion ... and increasingly dependant on,mathematics. Math is the fabric ...
Other Medicine News:Health News:Governor Strickland Signs House Bill 125 Into Law 2Health News:Review of group-based cancer trials reveals flaws in studies' design and analysis 2Health News:Review of group-based cancer trials reveals flaws in studies' design and analysis 3Health News:China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results 2Health News:China Medicine Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results 3Health News:Premature Birth Has Long-Lasting Effects 2Health News:Premature Birth Has Long-Lasting Effects 3Health News:Danny Calegari Appointed the Richard Merkin Distinguished Professor of Mathematics at the California Institute of Technology 2
(Date:12/14/2009)... -- Manchester Pharmaceuticals, Inc.(TM) announced today the availability ... October 22, 2009, the US Food and Drug ... patients suffering from gallstones in whom surgery poses ... advanced age. ,, Chenodal prescriptions have started to ... Resources ("Centric"), a specialty pharmacy company. Centric ...
(Date:12/14/2009)... -- Pf enex Inc. announced today ... an affiliate, an exclusive worldwide license to Pf ... technology for the production of specific proteins ... vaccine candidate. ,, Under the terms of the ... $52 million in upfront and milestone payments as well ...
(Date:12/14/2009)... N.J., Dec. 14 Watson Pharmaceuticals, Inc. ... new program encouraging health professionals to help maintain ... are on long-term androgen deprivation therapy (ADT). ... palliative treatment for prostate cancer that, while highly ... bone loss and increase a man,s risk for ...
Breaking Medicine Technology:Manchester Announces Availability of Chenodal(TM) 2Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 2Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 3Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 4Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 5Rodent smoke screen 11032 1Rodent smoke screen 11032 2Disability Firm Advocates for Valley 26apos 3Bs Needy Families 62842 1Disability Firm Advocates for Valley 26apos 3Bs Needy Families 62842 2Disability Firm Advocates for Valley 26apos 3Bs Needy Families 62842 3Music of Mozart Soothes the Preemie Baby 62837 1Music of Mozart Soothes the Preemie Baby 62837 2Music of Mozart Soothes the Preemie Baby 62837 3
... EXTON, Pa., April 16 ViroPharma Incorporated,(Nasdaq: ... Pharmaceuticals, a,division of Wyeth (NYSE: WYE ), ... the previously announced safety issue that emerged in ... C., "Clearly, this is a disappointing outcome ...
... April 16 Repligen Corporation,(Nasdaq: RGEN ) ... Administration,(FDA) has granted Fast Track designation to the ... the assessment of pancreatic,duct structures by magnetic resonance ... facilitate the development and expedite the review of,drugs ...
Other Medicine Technology:ViroPharma Announces Discontinuation of HCV-796 Development 2Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging 2Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging 3Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging 4
... was the first device ... after diagnostic and interventional ... It is a collagen-based ... for immediate sheath removal ...
InterVascular HemaPatch product line offers the vascular surgeon a range of collagen coated patches in a range of larger sizes angioplasty, or profundaplasty procedures without suture hole bleeding. ...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
... The Chito-Seal Topical Hemostasis Pad is intended for ... as vascular access sites and percutaneous catheters or ... chitosan gel, a powerful hemostatic agent. Chitosan gel ... marine biopolymer from which it is derived. When ...
Medicine Products: